Ueda E, Kinoshita T, Nojima J, Inoue K, Kitani T
Department of Clinical Research, Osaka University, Japan.
J Immunol. 1989 Aug 15;143(4):1274-7.
Fc gamma RIII (CD16), the type three receptor for the Fc portion of IgG, is expressed on neutrophils, killer (K)/NK lymphocytes and macrophages. K/NK lymphocyte Fc gamma RIII, which plays a role in antibody-dependent cellular cytotoxicity, is an efficient signal transducing molecule, whereas neutrophil Fc gamma RIII, which plays a role in immune-complex clearance, seems less efficient in signal transduction. Neutrophil Fc gamma RIII has been reported to be a glycan-phosphatidylinositol-anchored membrane protein. Our studies suggest that K/NK lymphocyte Fc gamma RIII is protein-anchored rather than glycan-phosphatidylinositol-anchored. That is, K/NK lymphocyte Fc gamma RIII was resistant to phosphatidylinositol-specific phospholipase C and surface expression of Fc gamma RIII was not affected on K/NK lymphocytes from patients with paroxysmal nocturnal hemoglobinuria, a disorder of hemopoietic stem cells resulting in deficient expression of glycan-phosphatidylinositol-anchored proteins. Different membrane anchoring mechanisms of the Fc gamma RIII may account for different consequences of the ligand binding to two cell types.
FcγRIII(CD16)是IgG Fc部分的Ⅲ型受体,在中性粒细胞、杀伤(K)/自然杀伤(NK)淋巴细胞和巨噬细胞上表达。K/NK淋巴细胞FcγRIII在抗体依赖性细胞毒性中起作用,是一种有效的信号转导分子,而在免疫复合物清除中起作用的中性粒细胞FcγRIII在信号转导方面似乎效率较低。据报道,中性粒细胞FcγRIII是一种糖基磷脂酰肌醇锚定的膜蛋白。我们的研究表明,K/NK淋巴细胞FcγRIII是蛋白锚定而非糖基磷脂酰肌醇锚定。也就是说,K/NK淋巴细胞FcγRIII对磷脂酰肌醇特异性磷脂酶C具有抗性,并且阵发性夜间血红蛋白尿(一种造血干细胞疾病,导致糖基磷脂酰肌醇锚定蛋白表达缺陷)患者的K/NK淋巴细胞上FcγRIII的表面表达不受影响。FcγRIII不同的膜锚定机制可能解释了配体与两种细胞类型结合的不同结果。